Charles River Laboratories Hits Day High with 10.24% Surge in Stock Price

Charles River Laboratories International, Inc. has experienced a significant uptick in its stock performance, gaining 10.24% on May 28, 2026. The stock reached an intraday high of USD 183.74, reflecting notable activity in the market. Despite this positive movement, the company faces challenges in its long-term financial fundamentals. The average Return on Capital Employed (ROCE) stands at 11.49%, indicating potential concerns regarding efficiency in generating profits from capital investments. Additionally, the net profit for the half-year period has decreased by 37.49%, amounting to USD 118.7 million, while the ROCE for the same period has dipped to -1.96%. The company has also seen a year-over-year increase in raw material costs by 5.87%, which may impact future profitability. Over the past year, Charles River Laboratories has generated a return of only 0.45%, significantly lagging behind the S&P 500's return of 14.11%. With a market capitalization of USD 7,503 million, the stock operates within the small-cap segment of the miscellaneous industry, characterized by a P/E ratio of 23.00 and a debt-to-equity ratio of 0.62.